Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience.
Yap, Desmond Y H
Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience. [electronic resource] - Nephrology (Carlton, Vic.) Nov 2012 - 676-80 p. digital
Publication Type: Journal Article
1440-1797
10.1111/j.1440-1797.2012.01646.x doi
Adrenal Cortex Hormones--therapeutic use
Adult
Cell Proliferation--drug effects
Drug Therapy, Combination
Everolimus
Female
Humans
Immunosuppressive Agents--adverse effects
Kidney--drug effects
Lupus Nephritis--drug therapy
Middle Aged
Protein Kinase Inhibitors--adverse effects
Retrospective Studies
Severity of Illness Index
Signal Transduction--drug effects
Sirolimus--adverse effects
TOR Serine-Threonine Kinases--antagonists & inhibitors
Tacrolimus--therapeutic use
Time Factors
Treatment Outcome
Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience. [electronic resource] - Nephrology (Carlton, Vic.) Nov 2012 - 676-80 p. digital
Publication Type: Journal Article
1440-1797
10.1111/j.1440-1797.2012.01646.x doi
Adrenal Cortex Hormones--therapeutic use
Adult
Cell Proliferation--drug effects
Drug Therapy, Combination
Everolimus
Female
Humans
Immunosuppressive Agents--adverse effects
Kidney--drug effects
Lupus Nephritis--drug therapy
Middle Aged
Protein Kinase Inhibitors--adverse effects
Retrospective Studies
Severity of Illness Index
Signal Transduction--drug effects
Sirolimus--adverse effects
TOR Serine-Threonine Kinases--antagonists & inhibitors
Tacrolimus--therapeutic use
Time Factors
Treatment Outcome